BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30963477)

  • 1. Early predictors of functional disability in Guillain-Barré Syndrome.
    Tunç A
    Acta Neurol Belg; 2019 Dec; 119(4):555-559. PubMed ID: 30963477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of serum inflammatory markers on the prognosis of adult and pediatric patients with Guillain-Barré syndrome.
    Ethemoglu O; Calik M
    Neuropsychiatr Dis Treat; 2018; 14():1255-1260. PubMed ID: 29805261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Cerebrospinal Fluid Total Protein and Serum Neutrophil-to-Lymphocyte Ratio with Clinical Outcomes of Guillain-Barre Syndrome Variants.
    Bano S; Nawaz A; Nasim A; Numan A; Zahid M
    J Coll Physicians Surg Pak; 2024 Feb; 34(2):187-192. PubMed ID: 38342870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain-Barré syndrome.
    Ozdemir HH
    Arq Neuropsiquiatr; 2016 Sep; 74(9):718-722. PubMed ID: 27706420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel prognostic system based on clinical and laboratory parameters for childhood Guillain-Barre syndrome.
    Tiwari I; Alam A; Kanta C; Koonwar S; Garg RK; Pandey S; Jain A; Kumar R
    Acta Neurol Belg; 2022 Oct; 122(5):1237-1245. PubMed ID: 35753018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated blood and cerebrospinal fluid glucose levels affect the severity and short-term prognosis of Guillain-Barré syndrome.
    Gong Q; Liu S; Xiao Z; Fu X; Lu Z
    Neurol Res; 2022 Feb; 44(2):121-127. PubMed ID: 34382919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-lymphocyte ratio in Guillain-Barré syndrome: A prognostic biomarker of severe disease and mechanical ventilation in Bangladesh.
    Jahan I; Ahmed R; Ahmed J; Khurshid S; Biswas PP; Upama IJ; Hamid Y; Papri N; Islam Z
    J Peripher Nerv Syst; 2023 Mar; 28(1):47-57. PubMed ID: 36700342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of lymphocyte-related immune-inflammatory biomarkers in detecting early progression of Guillain-Barré syndrome.
    Xu L; Gao TX; Chang SH; Jiang SM; Zhang LJ; Yang L
    J Clin Neurosci; 2022 Nov; 105():31-36. PubMed ID: 36063751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of Neutrophil-Lymphocyte Ratio with Clinical Severity in Patients with Guillain-Barre Syndrome.
    Banerjee S; Bhattacharjee M; Hossain MI; Hossain MS; Roy S; Shahiduzzaman M; Dey S; Losy SA
    Mymensingh Med J; 2023 Jul; 32(3):599-605. PubMed ID: 37391946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of systemic immune-inflammation index and platelet/neutrophil to lymphocyte ratio in Guillain-Barré syndrome.
    Liu T; Gao J; Liu M
    Clin Neurol Neurosurg; 2023 Dec; 235():108015. PubMed ID: 37898029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome.
    Altmann P; De Simoni D; Kaider A; Ludwig B; Rath J; Leutmezer F; Zimprich F; Hoeftberger R; Lunn MP; Heslegrave A; Berger T; Zetterberg H; Rommer PS
    J Neuroinflammation; 2020 Mar; 17(1):86. PubMed ID: 32183837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Admission sodium level and prognosis in adult Guillain-Barré syndrome.
    Sipilä JO; Kauko T; Soilu-Hänninen M
    Int J Neurosci; 2017 Apr; 127(4):344-349. PubMed ID: 26971365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtypes and Prognosis of Guillain-Barré Syndrome in Southwest China.
    Zhang G; Li Q; Zhang R; Wei X; Wang J; Qin X
    PLoS One; 2015; 10(7):e0133520. PubMed ID: 26200903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
    Verma R; Chaudhari TS; Raut TP; Garg RK
    J Neurol Sci; 2013 Dec; 335(1-2):105-11. PubMed ID: 24064258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are Cerebrospinal Fluid Protein Levels and Plasma Neutrophil/Lymphocyte Ratio Associated with Prognosis of Guillain Barré Syndrome?
    Sahin S; Cinar N; Karsidag S
    Neurol Int; 2017 Jun; 9(2):7032. PubMed ID: 28713530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between Acute Phase Reactants and Disability in Guillian-Barré Syndrome During the COVID-19 Pandemic.
    Yevgi R
    Arch Med Res; 2022 Feb; 53(2):179-185. PubMed ID: 34690009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a single-center-based early prognostic scoring system for Guillain-Barré syndrome.
    Di X; Wang J; Li L; Liu L
    BMC Neurol; 2023 Mar; 23(1):97. PubMed ID: 36870949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of patients with Guillain-Barré syndrome requiring mechanical ventilation.
    Netto AB; Taly AB; Kulkarni GB; Uma Maheshwara Rao GS; Rao S
    Neurol India; 2011; 59(5):707-11. PubMed ID: 22019655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain Barre Syndrome in the elderly: Experience from a tertiary-care hospital in India.
    Nagappa M; Rahul W; Sinha S; Bindu PS; Mathuranath PS; Rao S; Periyavan S; Umamaheshwara Rao GS; Taly AB
    J Clin Neurosci; 2017 Dec; 46():45-49. PubMed ID: 28890042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential association between COVID-19 disease and Guillain-Barré syndrome.
    Ergin Beton O; Ozturk Tan O; Bilen S
    Neurol Res; 2022 Sep; 44(9):855-860. PubMed ID: 35348038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.